Source: Poster Abstracts. Conference titles: American Association for Clinical Chemistry Annual Meeting (AACC). Unidade: FCF
Assunto: POLIMORFISMO
ABNT
HIRATA, Rosario Dominguez Crespo et al. Influence CYP2C9, CYP2C19 and VKROC1 gene polymorphisms on warfarin therapeutic requirements in Brazilian individuals. 2012, Anais.. Washington: AACC, 2012. . Acesso em: 21 ago. 2024.APA
Hirata, R. D. C., Cerda, A., Momesso, M., Saba, B., Sampaio, M. F., Castro, L. R. de, et al. (2012). Influence CYP2C9, CYP2C19 and VKROC1 gene polymorphisms on warfarin therapeutic requirements in Brazilian individuals. In Poster Abstracts. Washington: AACC.NLM
Hirata RDC, Cerda A, Momesso M, Saba B, Sampaio MF, Castro LR de, Lima PHO, Wang HTL, Silva MV, Fajardo CM, Oliveira CNB, Silva JC, Meneguelo Z, Sousa AGMR, Hirata MH. Influence CYP2C9, CYP2C19 and VKROC1 gene polymorphisms on warfarin therapeutic requirements in Brazilian individuals. Poster Abstracts. 2012 ;[citado 2024 ago. 21 ]Vancouver
Hirata RDC, Cerda A, Momesso M, Saba B, Sampaio MF, Castro LR de, Lima PHO, Wang HTL, Silva MV, Fajardo CM, Oliveira CNB, Silva JC, Meneguelo Z, Sousa AGMR, Hirata MH. Influence CYP2C9, CYP2C19 and VKROC1 gene polymorphisms on warfarin therapeutic requirements in Brazilian individuals. Poster Abstracts. 2012 ;[citado 2024 ago. 21 ]